Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; 2 of the 15 sources its claims cite were checked for support.

UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82

Open access

Abstract

Aims/hypothesis The aim of this project was to build a new version of the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS-OM1), a patient-level simulation tool for predicting lifetime health outcomes of people with type 2 diabetes mellitus.Methods Data from 5,102 UKPDS patients from the 20 year trial and the 4,031 survivors entering the 10 year post-trial monitoring period were used to derive parametric proportional hazards models predicting absolute risk of diabetes complications and death. We re-estimated the seven original event equations and estimated new equations for diabetic ulcer and some second events. The additional data permitted inclusion of new risk factor predictors such as estimated GFR. We also developed four new equations for all-cause mortality. Internal validation of model predictions of cumulative incidence of all events and death was carried out and a contemporary patient-level dataset was used to compare 10 year predictions from the original and the new models.Results Model equations were based on a median 17.6 years of follow-up and up to 89,760 patient-years of data, providing double the number of events, greater precision and a larger number of significant covariates. The new model, UKPDS-OM2, is internally valid over 25 years and predicts event rates for complications, which are lower than those from the existing model.Conclusions/interpretation The new UKPDS-OM2 has significant advantages over the existing model, as it captures more outcomes, is based on longer follow-up data, and more comprehensively captures the progression of diabetes. Its use will permit detailed and reliable lifetime simulations of key health outcomes in people with type 2 diabetes mellitus.

Overview

CoChat Summary

## TL;DR

The paper develops UKPDS-OM2, a patient-level simulation model for lifetime outcomes in type 2 diabetes, using longer follow-up from 5,102 UKPDS participants and 3,984 post-trial survivors. Compared with UKPDS-OM1, the new model includes more outcomes and risk factors, shows internal validity over 25 years, and generally predicts lower event rates and longer life expectancy.

## Key findings

  • The model equations were based on a median 17.6 years of follow-up and up to 89,760 patient-years of data, with at least twice as many events as in UKPDS-OM1 for each outcome; for example, 504 stroke events vs 157 in UKPDS-OM1.
  • Internal validation over 25 years found simulated curves within the 95% CIs of observed cumulative failure for all events and death; predictions stabilized at around 200 Monte Carlo replications.
  • In the contemporary external dataset (n = 3,984), UKPDS-OM2 predicted fewer events than UKPDS-OM1, including 10% vs 21% for myocardial infarction and 22.5% vs 31.6% for all-cause mortality; renal failure was 0.5% vs 1.3%.
  • Life expectancy predictions were higher with UKPDS-OM2 for all age groups examined; for ages 50–54, remaining life expectancy was 25.1 years with UKPDS-OM2 vs 20.0 years with UKPDS-OM1, and the 95% CIs were narrower.

## Methods

  • Patient-level epidemiological simulation model comparing UKPDS-OM2 with UKPDS-OM1; annual cycles estimate complications, death, life expectancy, and QALYs.
  • Risk equations were derived from 5,102 UKPDS participants with newly diagnosed type 2 diabetes (aged 25–65) plus 4,031 survivors in 10-year post-trial monitoring; external comparison used 3,984 patients from the Lipids in Diabetes Study.
  • Multivariate proportional hazards models were fit for complications and death, with internal validation against 25-year observed UKPDS outcomes, plus one-way deterministic sensitivity analysis and 1,000 Monte Carlo replications for life expectancy estimates.

## Limitations

  • The paper states that external validation is beyond the scope of this manuscript and will be addressed in future publications.
  • The authors note that complications such as hyperglycaemic and hypoglycaemic episodes are not included in the current model.
  • The text makes evident that comparisons with UKPDS-OM1 are limited because some endpoint definitions changed (for example, removal of vascular death from MI), and the external LDS dataset had no observed event rates because the study stopped early.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00125-013-2940-y

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

2 Valid · 0 Not valid · 10 Not checked · 56 Own results and interpretations

43 more claims

Create a free account to see all 68 claims and to verify the 13 references still open.

See all claims — free account
  • It may state two separate claims as one. 14
  • Probably not a substantial claim. 10

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Cited by

See all 495

Metadata

Authors
Hayes, A. J., Leal, J., Gray, A. M., Holman, R. R., & Clarke, P. M.
Affiliations
  • The University of Sydney (AU)
  • University of Oxford (GB)
  • Churchill Hospital (GB)
  • The University of Melbourne (AU)
Corresponding author
Hayes, A. J.
Venue
Diabetologia
Published
2013-06-22
Volume
56
Issue
9
Pages
1925-1933
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2091237544
Cited by
495
References
30
Citations by year
2026: 36 · 2025: 56 · 2024: 53 · 2023: 42 · 2022: 51 · 2021: 52 · 2020: 46 · 2019: 35 · 2018: 21 · 2017: 28 · 2016: 32 · 2015: 20 · 2014: 19 · 2013: 2
FWCI
19.14
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion)
Funders
  • National Institute for Health and Care Research (NF-SI-0509-10206)
  • University of Oxford
  • Medical Research Council (87386)
  • National Health and Medical Research Council (512463, 571372)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, risk prediction model, proportional hazards model, diabetes complications, all-cause mortality, diabetic ulcers, estimated glomerular filtration rate, internal validation
MeSH terms
Adult, Aged, Diabetes Mellitus, Type 2, Female, United Kingdom, Humans, Male, Middle Aged, Models, Theoretical, Prospective Studies, Outcome Assessment, Health Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82. https://app.cochat.ai/papers/10.1007/s00125-013-2940-y
The paper
Hayes, A. J., Leal, J., Gray, A. M., Holman, R. R., & Clarke, P. M. (2013). UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82. Diabetologia. https://doi.org/10.1007/s00125-013-2940-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.